Scarica l'app Stockscreener
3.17
3.94%
-0.13
Pre-mercato:
3.17
Psyence Biomedical Ltd Borsa (PBM) Ultime notizie
PBM Stock On Track For Best Session On Report Of Upcoming Trump Executive Order On Psychedelic Ibogaine - Stocktwits
Jeffrey Weiner holds 59,750 shares in PSYENCE BIOMEDICAL LTD. (PBM) - Stock Titan
Psyence Biomedical Company Profile & Introduction - Moomoo
PBM News | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
Psyence Biomedical Corrects Technical Error in 2023 Equity Incentive Plan - TipRanks
Psyence Biomedical (PBM) corrects error in 2023 equity incentive plan - Stock Titan
Psyence Biomedical draws attention premarket after filing on 30% stake - Bez Kabli
Psyence Biomedical (PBM) Surges Over 7%: Bullish Momentum Builds Near ResistanceEnding Diagonal - newsline.com
Psyence Labs Discloses Investment in PSYENCE BIOMEDICAL LTD. with 30.05% Stake - TradingView
Psyence Labs gains 30.05% ownership of Psyence Biomedical (PBM) - Stock Titan
Psyence Biomedical Ltd. Warrant (PBMWW) Slides 8.94% as Stock Hovers at $0.03Market Cap Weight - The Legal Advocate
Psyence Biomedical (PBM) Rallies 5.85% as Shares Test Key Resistance Near $4.56Value Area High - The Legal Advocate
Psyence Biomedical Ltd. (PBM) Edges Higher Amid Sector Rotation and Key Technical LevelsUpthrust Pattern - The Legal Advocate
Psyence Biomedical Warrants (PBMWW) Edge Higher; Support and Resistance Converge at $0.03Momentum Breakout Ideas - The Legal Advocate
$Psyence Biomedical (PBM.US)$ picked me up lets goooo - Moomoo
Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
PBM Stock Chart | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
TradingKey - TradingKey
Is Psyence (PBMWW) stock hiding in plain sight? (+6.50%) 2026-05-08Theta Decay - newser.com
Psyence Biomedical Ltd. Common Shares (PBM) Live Share Price, Invest From India - INDmoney
12 Health Care Stocks Moving In Friday's Pre-Market SessionAkanda (NASDAQ:AKAN), Akari Therapeutics (N - Benzinga
Short sales on the TSX: What bearish investors are betting against - The Globe and Mail
Psyence Biomedical shares rise following equity investment agreement - MSN
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Why is Psyence Biomedical stock falling Wednesday? - MSN
Trending Stocks Today | Psyence Biomedical Soars 130.26% Pre-Market - Moomoo
Psyence Biomedical doses first patient in psilocybin cancer trial By Investing.com - Investing.com Australia
PBM jumps on Trump psychedelic push, ibogaine supply story - MSN
Psyence BioMed Begins Phase IIb Dosing of Psilocybin Candidate NPX-5 in Australian Cancer Adjustment Disorder Trial - TipRanks
Psyence BioMed (Nasdaq: PBM) doses first patient in NPX-5 Phase IIb trial - Stock Titan
Why Is Psyence Biomedical Stock Falling Wednesday? - Sahm
Psyence Biomedical doses first patient in psilocybin cancer trial - Investing.com
Psyence Biomedical (PBM) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder - The Manila Times
Psyence Biomedical Ltd. Begins Phase IIb Clinical Trial for NPX-5 Psilocybin Treatment in Cancer Patients - Quiver Quantitative
PBMWW Psyence highlights clinical trial progress as core strategic priority in its latest quarterly earnings release.Community Watchlist - Cổng thông tin điện tử Tỉnh Sơn La
Why is Psyence Biomedical stock trading lower on Tuesday? - MSN
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):